- Available history
- No dated observations
- Data captured
IPO Date coverage
Maze Therapeutics, Inc. (MAZE). What the retained company guidance contains and how many periods can be scored.
- Legal name: Value Maze Therapeutics, Inc..
- Ticker: Value MAZE.
- Exchange: Value Nasdaq.
- IPO date: Value 31 Jan 2025.
| Measure | Value |
|---|---|
| Legal name | Maze Therapeutics, Inc. |
| Ticker | MAZE |
| Exchange | Nasdaq |
| IPO date | 31 Jan 2025 |
| Country of operation (business address) | United States |
| Final IPO prospectus | Form 424B4 filed 2025-01-31, accession 0001193125-25-018482 |
| Registration statement | Form S-1 filed 2025-01-07, accession 0001193125-25-002851 |
| Current registered country | Delaware, United States SEC EDGAR state of incorporation DE |
| Business address | 171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO, California, 94080, United States |
| Mailing address | 171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO, California, 94080, United States |
| Industry (SIC) | 2836 Biological Products, (No Diagnostic Substances) |
| Fiscal year end | 12-31 |
| Filer category | <br>Emerging growth company |
| Listed stock (Section 12(b)) | Common Stock - par value $0.001 per share · MAZE · NASDAQ 10-Q filed 2026-08-11 cover |
| Shell company | No 10-Q filed 2026-08-11 cover |
| Smaller reporting company | No 10-Q filed 2026-08-11 cover |
| Emerging growth company | Yes 10-Q filed 2026-08-11 cover |
| Current in its reporting | Yes 10-Q filed 2026-08-11 cover |
| Well-known seasoned issuer | Yes 10-K filed 2026-03-25 cover |
| Voluntary filer | No 10-K filed 2026-03-25 cover |
| First EDGAR filing | 2024-06-21 (DRS) |
| SEC CIK | 1842295 |
| EIN | 000000000 |
| Phone | 6508505070 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |